| Name | Clopamide |
|---|---|
| Synonyms |
EINECS 211-261-7
Brinaldix DT-327 4-Chloro-N-[(2R,6S)-2,6-dimethyl-1-piperidinyl]-3-sulfamoylbenzamide Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,6-dimethyl-1-piperidinyl)-, cis- CLOPAMIDUM ChlosudiMepriMyl Adurix MFCD00941495 4-Chloro-N-(2,6-dimethylpiperidino)-3-sulfamoylbenzamide 3-(aminosulfonyl)-4-chloro-N-(2,6-dimethylpiperidin-1-yl)benzamide Aquex 4-Chloro-N-(2,6-dimethylpiperidin-1-yl)-3-sulfamoylbenzamide Benzamide, 3-(aminosulfonyl)-4-chloro-N-[(2R,6S)-2,6-dimethyl-1-piperidinyl]- Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,6-dimethyl-1-piperidinyl)- 4-Chloro-N-(2,6-dimethyl-1-piperidinyl)-3-sulfamoylbenzamide |
| Description | Clopamide is an orally active thiazide-like diuretic agent that inhibits the sodium-coupled chloride cotransporter SLC12A3. Clopamide has the potential for hypertension and cardiac failure research[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Clopamide is actively secreted by renal tubular cells and the True Tubular Excretion Fraction (TTEF) value is 10%[3]. |
| In Vivo | The venoconstrictor response to bradykinin is attenuated after oral administration of Clopamide (0.5 mg/kg), and by concomitant local infusion of cyclosporine-A (1-10 μg/min) in conscious dogs[4]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Melting Point | 244-246ºC |
| Molecular Formula | C14H20ClN3O3S |
| Molecular Weight | 345.845 |
| Exact Mass | 345.091400 |
| PSA | 100.88000 |
| LogP | 1.59 |
| Index of Refraction | 1.613 |
| Storage condition | 2-8°C |
| Symbol |
GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H317-H334 |
| Precautionary Statements | P261-P280-P284-P304 + P340-P342 + P311 |
| Hazard Codes | Xn |
| Risk Phrases | R42/43 |
| Safety Phrases | 36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2935009090 |
| HS Code | 2935009090 |
|---|---|
| Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |